In contrast, in patients with SS, we found no association between IgE-anti-SSA- or -SSB-antibodies and clinical activity, a fact which seems logical since this is already known for the IgG-antibodies but had not yet been analysed in detail for the IgE-antibodies. This evidence concerns the gene CALR and synovial sarcoma.